Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30 USD | +1.20% | +10.36% | -10.64% |
05-08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
05-07 | Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.64% | 1.38B | |
+32.55% | 698B | |
+26.51% | 568B | |
-4.64% | 358B | |
+19.15% | 328B | |
+3.61% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.35% | 165B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira BioSciences Names Frank D. Lee CEO, Board Member